Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-12

AUTHORS

Amalendu P Ranjan, Anindita Mukerjee, Lawrence Helson, Jamboor K Vishwanatha

ABSTRACT

BACKGROUND: Nanoparticle based delivery of anticancer drugs have been widely investigated. However, a very important process for Research & Development in any pharmaceutical industry is scaling nanoparticle formulation techniques so as to produce large batches for preclinical and clinical trials. This process is not only critical but also difficult as it involves various formulation parameters to be modulated all in the same process. METHODS: In our present study, we formulated curcumin loaded poly (lactic acid-co-glycolic acid) nanoparticles (PLGA-CURC). This improved the bioavailability of curcumin, a potent natural anticancer drug, making it suitable for cancer therapy. Post formulation, we optimized our process by Reponse Surface Methodology (RSM) using Central Composite Design (CCD) and scaled up the formulation process in four stages with final scale-up process yielding 5 g of curcumin loaded nanoparticles within the laboratory setup. The nanoparticles formed after scale-up process were characterized for particle size, drug loading and encapsulation efficiency, surface morphology, in vitro release kinetics and pharmacokinetics. Stability analysis and gamma sterilization were also carried out. RESULTS: Results revealed that that process scale-up is being mastered for elaboration to 5 g level. The mean nanoparticle size of the scaled up batch was found to be 158.5±9.8 nm and the drug loading was determined to be 10.32±1.4%. The in vitro release study illustrated a slow sustained release corresponding to 75% drug over a period of 10 days. The pharmacokinetic profile of PLGA-CURC in rats following i.v. administration showed two compartmental model with the area under the curve (AUC0-∞) being 6.139 mg/L h. Gamma sterilization showed no significant change in the particle size or drug loading of the nanoparticles. Stability analysis revealed long term physiochemical stability of the PLGA-CURC formulation. CONCLUSIONS: A successful effort towards formulating, optimizing and scaling up PLGA-CURC by using Solid-Oil/Water emulsion technique was demonstrated. The process used CCD-RSM for optimization and further scaled up to produce 5 g of PLGA-CURC with almost similar physicochemical characteristics as that of the primary formulated batch. More... »

PAGES

38

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1477-3155-10-38

DOI

http://dx.doi.org/10.1186/1477-3155-10-38

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1014874253

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22937885


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0306", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Chemistry (incl. Structural)", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Curcumin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Carriers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Stability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lactic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Microscopy, Confocal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Chemical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanoparticles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Particle Size", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polyglycolic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Sprague-Dawley", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Research Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transcription Factor RelA", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of North Texas Health Science Center", 
          "id": "https://www.grid.ac/institutes/grid.266871.c", 
          "name": [
            "Department of Molecular Biology & Immunology and Institute for Cancer Research, Graduate School of Biomedical Sciences, University of North Texas Health Science Center, 76107, Fort Worth, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ranjan", 
        "givenName": "Amalendu P", 
        "id": "sg:person.0702554625.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702554625.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of North Texas Health Science Center", 
          "id": "https://www.grid.ac/institutes/grid.266871.c", 
          "name": [
            "Department of Molecular Biology & Immunology and Institute for Cancer Research, Graduate School of Biomedical Sciences, University of North Texas Health Science Center, 76107, Fort Worth, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mukerjee", 
        "givenName": "Anindita", 
        "id": "sg:person.01203736343.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203736343.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "SignPath Pharmaceuticals Inc, Quakertown, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Helson", 
        "givenName": "Lawrence", 
        "id": "sg:person.0671324400.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671324400.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of North Texas Health Science Center", 
          "id": "https://www.grid.ac/institutes/grid.266871.c", 
          "name": [
            "Department of Molecular Biology & Immunology and Institute for Cancer Research, Graduate School of Biomedical Sciences, University of North Texas Health Science Center, 76107, Fort Worth, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vishwanatha", 
        "givenName": "Jamboor K", 
        "id": "sg:person.0747516710.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747516710.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1211/0022357056145", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000190052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bmc.795", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000384874"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2009.04.045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001694367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1088/0957-4484/22/29/295104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004077122"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0945-053x(02)00007-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004622721"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11051-010-9907-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004700764", 
          "https://doi.org/10.1007/s11051-010-9907-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11051-010-9907-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004700764", 
          "https://doi.org/10.1007/s11051-010-9907-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.addr.2006.09.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004829869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0928-0987(03)00048-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004891465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0928-0987(03)00048-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004891465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2009.06.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005624862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-04-0744", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005777798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.phymed.2009.04.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007104432"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0168-3659(02)00127-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016356395"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1088/0957-4484/22/4/045101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016473251"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1088/0957-4484/22/4/045101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016473251"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2005.12.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019030001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10856-006-8940-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019759297", 
          "https://doi.org/10.1007/s10856-006-8940-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0378-5173(96)04854-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019942185"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2009.02.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021088722"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-3155-5-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022264103", 
          "https://doi.org/10.1186/1477-3155-5-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-08-1957", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022589290"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.biomaterials.2010.04.062", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022925716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2008.08.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024533252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0278-6915(02)00258-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025649519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0278-6915(02)00258-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025649519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.seppur.2007.09.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025778528"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2010.08.033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026393875"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2006.12.043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027033711"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drudis.2011.09.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030898701"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nano.2011.07.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032707596"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2007.09.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034318659"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp700113r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034955222"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp700113r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034955222"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2010.03.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037770056"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1248/cpb.54.977", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039457151"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0928-0987(01)00095-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041280693"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1211/jpp.61.03.0005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044389552"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tips.2009.04.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046996104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ijn.s17386", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047104794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejps.2009.02.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049067143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/03639045.2011.563781", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049089983"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.powtec.2009.09.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051563586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bmc.1244", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051768727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bmc.1244", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051768727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2006.09.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053212930"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1214/aoms/1177707047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064401263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/092986710790149738", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069161671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/138920012798356952", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069176048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074955168", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1211/jpp/61.03.0005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077850891"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077974252", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/00224065.1980.11980968", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101183642"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-12", 
    "datePublishedReg": "2012-12-01", 
    "description": "BACKGROUND: Nanoparticle based delivery of anticancer drugs have been widely investigated. However, a very important process for Research & Development in any pharmaceutical industry is scaling nanoparticle formulation techniques so as to produce large batches for preclinical and clinical trials. This process is not only critical but also difficult as it involves various formulation parameters to be modulated all in the same process.\nMETHODS: In our present study, we formulated curcumin loaded poly (lactic acid-co-glycolic acid) nanoparticles (PLGA-CURC). This improved the bioavailability of curcumin, a potent natural anticancer drug, making it suitable for cancer therapy. Post formulation, we optimized our process by Reponse Surface Methodology (RSM) using Central Composite Design (CCD) and scaled up the formulation process in four stages with final scale-up process yielding 5 g of curcumin loaded nanoparticles within the laboratory setup. The nanoparticles formed after scale-up process were characterized for particle size, drug loading and encapsulation efficiency, surface morphology, in vitro release kinetics and pharmacokinetics. Stability analysis and gamma sterilization were also carried out.\nRESULTS: Results revealed that that process scale-up is being mastered for elaboration to 5 g level. The mean nanoparticle size of the scaled up batch was found to be 158.5\u00b19.8 nm and the drug loading was determined to be 10.32\u00b11.4%. The in vitro release study illustrated a slow sustained release corresponding to 75% drug over a period of 10 days. The pharmacokinetic profile of PLGA-CURC in rats following i.v. administration showed two compartmental model with the area under the curve (AUC0-\u221e) being 6.139 mg/L h. Gamma sterilization showed no significant change in the particle size or drug loading of the nanoparticles. Stability analysis revealed long term physiochemical stability of the PLGA-CURC formulation.\nCONCLUSIONS: A successful effort towards formulating, optimizing and scaling up PLGA-CURC by using Solid-Oil/Water emulsion technique was demonstrated. The process used CCD-RSM for optimization and further scaled up to produce 5 g of PLGA-CURC with almost similar physicochemical characteristics as that of the primary formulated batch.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1477-3155-10-38", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7821992", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1031280", 
        "issn": [
          "1477-3155"
        ], 
        "name": "Journal of Nanobiotechnology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "name": "Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy", 
    "pagination": "38", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "46ddcf245630edb02dcc6fc00efd450de7a74ee330b538a825b6df36d6b0ab84"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22937885"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101152208"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1477-3155-10-38"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1014874253"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1477-3155-10-38", 
      "https://app.dimensions.ai/details/publication/pub.1014874253"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000549.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1477-3155-10-38"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1477-3155-10-38'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1477-3155-10-38'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1477-3155-10-38'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1477-3155-10-38'


 

This table displays all metadata directly associated to this object as RDF triples.

307 TRIPLES      21 PREDICATES      94 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1477-3155-10-38 schema:about N00d03974be1e4c4abe4cb7651bd1b568
2 N08864fd242a24de2a82c018fb26df022
3 N0f23742b35e741e79efc102e026dfad0
4 N3fbb010d12364708afe1f2b2560735db
5 N48ee5a57750a4f7582aa08b6c090d86f
6 N4b7b744e85664ba1ab1f15e894fc8407
7 N4ce715c7e87b416f9f5c74dc4d6de02c
8 N68d823a3eaf348c4bed5034474692f80
9 N7f1357000a0548f484a596c8be5dfaa7
10 N9ccc2ecae4f24cdd99ca2c75da11c618
11 Na3a432859cb14fc99bd12aa2f4311460
12 Naf136852f6a8453ebc083453ccb309aa
13 Nb2d9c051ca9547769d210efbb1f69ff4
14 Nb45cad6e2ce34c3ea43aa2cc8af83311
15 Nbcd9a01cce9b48e3be7f7b8b2b0a4024
16 Nd53e0720a4a943bea3896bffc75c102e
17 Ndaaa6703eb9f426193cba58e7a2fd4b0
18 Ndce6432ae0a145eb8ea19ab981250f63
19 anzsrc-for:03
20 anzsrc-for:0306
21 schema:author N2b3012a5cf97441385869d808fe0b325
22 schema:citation sg:pub.10.1007/s10856-006-8940-4
23 sg:pub.10.1007/s11051-010-9907-4
24 sg:pub.10.1186/1477-3155-5-3
25 https://app.dimensions.ai/details/publication/pub.1074955168
26 https://app.dimensions.ai/details/publication/pub.1077974252
27 https://doi.org/10.1002/bmc.1244
28 https://doi.org/10.1002/bmc.795
29 https://doi.org/10.1016/j.addr.2006.09.017
30 https://doi.org/10.1016/j.biomaterials.2010.04.062
31 https://doi.org/10.1016/j.drudis.2011.09.009
32 https://doi.org/10.1016/j.ejpb.2007.09.009
33 https://doi.org/10.1016/j.ejpb.2009.02.002
34 https://doi.org/10.1016/j.ejpb.2009.06.002
35 https://doi.org/10.1016/j.ejps.2009.02.019
36 https://doi.org/10.1016/j.ijpharm.2005.12.013
37 https://doi.org/10.1016/j.ijpharm.2006.09.025
38 https://doi.org/10.1016/j.ijpharm.2006.12.043
39 https://doi.org/10.1016/j.ijpharm.2008.08.009
40 https://doi.org/10.1016/j.ijpharm.2009.04.045
41 https://doi.org/10.1016/j.ijpharm.2010.03.034
42 https://doi.org/10.1016/j.ijpharm.2010.08.033
43 https://doi.org/10.1016/j.nano.2011.07.011
44 https://doi.org/10.1016/j.phymed.2009.04.008
45 https://doi.org/10.1016/j.powtec.2009.09.004
46 https://doi.org/10.1016/j.seppur.2007.09.005
47 https://doi.org/10.1016/j.tips.2009.04.005
48 https://doi.org/10.1016/s0168-3659(02)00127-x
49 https://doi.org/10.1016/s0278-6915(02)00258-2
50 https://doi.org/10.1016/s0378-5173(96)04854-5
51 https://doi.org/10.1016/s0928-0987(01)00095-1
52 https://doi.org/10.1016/s0928-0987(03)00048-4
53 https://doi.org/10.1016/s0945-053x(02)00007-0
54 https://doi.org/10.1021/mp700113r
55 https://doi.org/10.1080/00224065.1980.11980968
56 https://doi.org/10.1088/0957-4484/22/29/295104
57 https://doi.org/10.1088/0957-4484/22/4/045101
58 https://doi.org/10.1158/1078-0432.ccr-04-0744
59 https://doi.org/10.1158/1078-0432.ccr-08-1957
60 https://doi.org/10.1211/0022357056145
61 https://doi.org/10.1211/jpp.61.03.0005
62 https://doi.org/10.1211/jpp/61.03.0005
63 https://doi.org/10.1214/aoms/1177707047
64 https://doi.org/10.1248/cpb.54.977
65 https://doi.org/10.2147/ijn.s17386
66 https://doi.org/10.2174/092986710790149738
67 https://doi.org/10.2174/138920012798356952
68 https://doi.org/10.3109/03639045.2011.563781
69 schema:datePublished 2012-12
70 schema:datePublishedReg 2012-12-01
71 schema:description BACKGROUND: Nanoparticle based delivery of anticancer drugs have been widely investigated. However, a very important process for Research & Development in any pharmaceutical industry is scaling nanoparticle formulation techniques so as to produce large batches for preclinical and clinical trials. This process is not only critical but also difficult as it involves various formulation parameters to be modulated all in the same process. METHODS: In our present study, we formulated curcumin loaded poly (lactic acid-co-glycolic acid) nanoparticles (PLGA-CURC). This improved the bioavailability of curcumin, a potent natural anticancer drug, making it suitable for cancer therapy. Post formulation, we optimized our process by Reponse Surface Methodology (RSM) using Central Composite Design (CCD) and scaled up the formulation process in four stages with final scale-up process yielding 5 g of curcumin loaded nanoparticles within the laboratory setup. The nanoparticles formed after scale-up process were characterized for particle size, drug loading and encapsulation efficiency, surface morphology, in vitro release kinetics and pharmacokinetics. Stability analysis and gamma sterilization were also carried out. RESULTS: Results revealed that that process scale-up is being mastered for elaboration to 5 g level. The mean nanoparticle size of the scaled up batch was found to be 158.5±9.8 nm and the drug loading was determined to be 10.32±1.4%. The in vitro release study illustrated a slow sustained release corresponding to 75% drug over a period of 10 days. The pharmacokinetic profile of PLGA-CURC in rats following i.v. administration showed two compartmental model with the area under the curve (AUC0-∞) being 6.139 mg/L h. Gamma sterilization showed no significant change in the particle size or drug loading of the nanoparticles. Stability analysis revealed long term physiochemical stability of the PLGA-CURC formulation. CONCLUSIONS: A successful effort towards formulating, optimizing and scaling up PLGA-CURC by using Solid-Oil/Water emulsion technique was demonstrated. The process used CCD-RSM for optimization and further scaled up to produce 5 g of PLGA-CURC with almost similar physicochemical characteristics as that of the primary formulated batch.
72 schema:genre research_article
73 schema:inLanguage en
74 schema:isAccessibleForFree true
75 schema:isPartOf N788d492df9124a908bb165faad763e91
76 Ndcfa7cd4feb746c183d9b5faa42d84ca
77 sg:journal.1031280
78 schema:name Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy
79 schema:pagination 38
80 schema:productId N3d54199799a94daa98f4d64e375685d8
81 N8342c533e2a543f4b07fe0fdea7459dd
82 N9e7bcb83ac5443c4bdf6546e063f7599
83 Ne2163304611444ed92ea917092f965ac
84 Ne5cd13527730451580d95087905d4c25
85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014874253
86 https://doi.org/10.1186/1477-3155-10-38
87 schema:sdDatePublished 2019-04-10T15:58
88 schema:sdLicense https://scigraph.springernature.com/explorer/license/
89 schema:sdPublisher N4dabf35cfcf5415caa3aadc15782f476
90 schema:url http://link.springer.com/10.1186%2F1477-3155-10-38
91 sgo:license sg:explorer/license/
92 sgo:sdDataset articles
93 rdf:type schema:ScholarlyArticle
94 N00d03974be1e4c4abe4cb7651bd1b568 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Curcumin
96 rdf:type schema:DefinedTerm
97 N08864fd242a24de2a82c018fb26df022 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Microscopy, Confocal
99 rdf:type schema:DefinedTerm
100 N0f23742b35e741e79efc102e026dfad0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Particle Size
102 rdf:type schema:DefinedTerm
103 N2b3012a5cf97441385869d808fe0b325 rdf:first sg:person.0702554625.45
104 rdf:rest N4cee3fb479824459abcaf632490483d0
105 N3d54199799a94daa98f4d64e375685d8 schema:name doi
106 schema:value 10.1186/1477-3155-10-38
107 rdf:type schema:PropertyValue
108 N3fbb010d12364708afe1f2b2560735db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Antineoplastic Agents
110 rdf:type schema:DefinedTerm
111 N40562c87a14943328ed94891bd4c6a72 rdf:first sg:person.0671324400.35
112 rdf:rest Nf933824bc73a484dbb156b7152a3b095
113 N48ee5a57750a4f7582aa08b6c090d86f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Rats, Sprague-Dawley
115 rdf:type schema:DefinedTerm
116 N4b7b744e85664ba1ab1f15e894fc8407 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Animals
118 rdf:type schema:DefinedTerm
119 N4ce715c7e87b416f9f5c74dc4d6de02c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Transcription Factor RelA
121 rdf:type schema:DefinedTerm
122 N4cee3fb479824459abcaf632490483d0 rdf:first sg:person.01203736343.38
123 rdf:rest N40562c87a14943328ed94891bd4c6a72
124 N4dabf35cfcf5415caa3aadc15782f476 schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 N68d823a3eaf348c4bed5034474692f80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Rats
128 rdf:type schema:DefinedTerm
129 N754a45f98d5b40ff9704122816543dce schema:name SignPath Pharmaceuticals Inc, Quakertown, PA, USA
130 rdf:type schema:Organization
131 N788d492df9124a908bb165faad763e91 schema:volumeNumber 10
132 rdf:type schema:PublicationVolume
133 N7f1357000a0548f484a596c8be5dfaa7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Polyglycolic Acid
135 rdf:type schema:DefinedTerm
136 N8342c533e2a543f4b07fe0fdea7459dd schema:name pubmed_id
137 schema:value 22937885
138 rdf:type schema:PropertyValue
139 N9ccc2ecae4f24cdd99ca2c75da11c618 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Nanoparticles
141 rdf:type schema:DefinedTerm
142 N9e7bcb83ac5443c4bdf6546e063f7599 schema:name dimensions_id
143 schema:value pub.1014874253
144 rdf:type schema:PropertyValue
145 Na3a432859cb14fc99bd12aa2f4311460 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Lactic Acid
147 rdf:type schema:DefinedTerm
148 Naf136852f6a8453ebc083453ccb309aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Drug Carriers
150 rdf:type schema:DefinedTerm
151 Nb2d9c051ca9547769d210efbb1f69ff4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Research Design
153 rdf:type schema:DefinedTerm
154 Nb45cad6e2ce34c3ea43aa2cc8af83311 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Humans
156 rdf:type schema:DefinedTerm
157 Nbcd9a01cce9b48e3be7f7b8b2b0a4024 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Cell Line, Tumor
159 rdf:type schema:DefinedTerm
160 Nd53e0720a4a943bea3896bffc75c102e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Models, Chemical
162 rdf:type schema:DefinedTerm
163 Ndaaa6703eb9f426193cba58e7a2fd4b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Male
165 rdf:type schema:DefinedTerm
166 Ndce6432ae0a145eb8ea19ab981250f63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Drug Stability
168 rdf:type schema:DefinedTerm
169 Ndcfa7cd4feb746c183d9b5faa42d84ca schema:issueNumber 1
170 rdf:type schema:PublicationIssue
171 Ne2163304611444ed92ea917092f965ac schema:name nlm_unique_id
172 schema:value 101152208
173 rdf:type schema:PropertyValue
174 Ne5cd13527730451580d95087905d4c25 schema:name readcube_id
175 schema:value 46ddcf245630edb02dcc6fc00efd450de7a74ee330b538a825b6df36d6b0ab84
176 rdf:type schema:PropertyValue
177 Nf933824bc73a484dbb156b7152a3b095 rdf:first sg:person.0747516710.37
178 rdf:rest rdf:nil
179 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
180 schema:name Chemical Sciences
181 rdf:type schema:DefinedTerm
182 anzsrc-for:0306 schema:inDefinedTermSet anzsrc-for:
183 schema:name Physical Chemistry (incl. Structural)
184 rdf:type schema:DefinedTerm
185 sg:grant.7821992 http://pending.schema.org/fundedItem sg:pub.10.1186/1477-3155-10-38
186 rdf:type schema:MonetaryGrant
187 sg:journal.1031280 schema:issn 1477-3155
188 schema:name Journal of Nanobiotechnology
189 rdf:type schema:Periodical
190 sg:person.01203736343.38 schema:affiliation https://www.grid.ac/institutes/grid.266871.c
191 schema:familyName Mukerjee
192 schema:givenName Anindita
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203736343.38
194 rdf:type schema:Person
195 sg:person.0671324400.35 schema:affiliation N754a45f98d5b40ff9704122816543dce
196 schema:familyName Helson
197 schema:givenName Lawrence
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671324400.35
199 rdf:type schema:Person
200 sg:person.0702554625.45 schema:affiliation https://www.grid.ac/institutes/grid.266871.c
201 schema:familyName Ranjan
202 schema:givenName Amalendu P
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702554625.45
204 rdf:type schema:Person
205 sg:person.0747516710.37 schema:affiliation https://www.grid.ac/institutes/grid.266871.c
206 schema:familyName Vishwanatha
207 schema:givenName Jamboor K
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747516710.37
209 rdf:type schema:Person
210 sg:pub.10.1007/s10856-006-8940-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019759297
211 https://doi.org/10.1007/s10856-006-8940-4
212 rdf:type schema:CreativeWork
213 sg:pub.10.1007/s11051-010-9907-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004700764
214 https://doi.org/10.1007/s11051-010-9907-4
215 rdf:type schema:CreativeWork
216 sg:pub.10.1186/1477-3155-5-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022264103
217 https://doi.org/10.1186/1477-3155-5-3
218 rdf:type schema:CreativeWork
219 https://app.dimensions.ai/details/publication/pub.1074955168 schema:CreativeWork
220 https://app.dimensions.ai/details/publication/pub.1077974252 schema:CreativeWork
221 https://doi.org/10.1002/bmc.1244 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051768727
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1002/bmc.795 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000384874
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/j.addr.2006.09.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004829869
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1016/j.biomaterials.2010.04.062 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022925716
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1016/j.drudis.2011.09.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030898701
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1016/j.ejpb.2007.09.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034318659
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1016/j.ejpb.2009.02.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021088722
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1016/j.ejpb.2009.06.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005624862
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1016/j.ejps.2009.02.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049067143
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1016/j.ijpharm.2005.12.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019030001
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1016/j.ijpharm.2006.09.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053212930
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1016/j.ijpharm.2006.12.043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027033711
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1016/j.ijpharm.2008.08.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024533252
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1016/j.ijpharm.2009.04.045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001694367
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1016/j.ijpharm.2010.03.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037770056
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1016/j.ijpharm.2010.08.033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026393875
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1016/j.nano.2011.07.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032707596
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1016/j.phymed.2009.04.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007104432
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1016/j.powtec.2009.09.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051563586
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1016/j.seppur.2007.09.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025778528
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1016/j.tips.2009.04.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046996104
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1016/s0168-3659(02)00127-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1016356395
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1016/s0278-6915(02)00258-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025649519
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1016/s0378-5173(96)04854-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019942185
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1016/s0928-0987(01)00095-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041280693
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1016/s0928-0987(03)00048-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004891465
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1016/s0945-053x(02)00007-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004622721
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1021/mp700113r schema:sameAs https://app.dimensions.ai/details/publication/pub.1034955222
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1080/00224065.1980.11980968 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101183642
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1088/0957-4484/22/29/295104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004077122
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1088/0957-4484/22/4/045101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016473251
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1158/1078-0432.ccr-04-0744 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005777798
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1158/1078-0432.ccr-08-1957 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022589290
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1211/0022357056145 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000190052
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1211/jpp.61.03.0005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044389552
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1211/jpp/61.03.0005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077850891
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1214/aoms/1177707047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064401263
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1248/cpb.54.977 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039457151
296 rdf:type schema:CreativeWork
297 https://doi.org/10.2147/ijn.s17386 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047104794
298 rdf:type schema:CreativeWork
299 https://doi.org/10.2174/092986710790149738 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069161671
300 rdf:type schema:CreativeWork
301 https://doi.org/10.2174/138920012798356952 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069176048
302 rdf:type schema:CreativeWork
303 https://doi.org/10.3109/03639045.2011.563781 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049089983
304 rdf:type schema:CreativeWork
305 https://www.grid.ac/institutes/grid.266871.c schema:alternateName University of North Texas Health Science Center
306 schema:name Department of Molecular Biology & Immunology and Institute for Cancer Research, Graduate School of Biomedical Sciences, University of North Texas Health Science Center, 76107, Fort Worth, TX, USA
307 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...